MX345291B - Microgranulos y microtabletas resistentes a uso inapropiado. - Google Patents
Microgranulos y microtabletas resistentes a uso inapropiado.Info
- Publication number
- MX345291B MX345291B MX2012014270A MX2012014270A MX345291B MX 345291 B MX345291 B MX 345291B MX 2012014270 A MX2012014270 A MX 2012014270A MX 2012014270 A MX2012014270 A MX 2012014270A MX 345291 B MX345291 B MX 345291B
- Authority
- MX
- Mexico
- Prior art keywords
- diversion
- microtablets
- active principle
- microgranules
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención se refiere al uso de una forma de dosis oral basada en microgránulos y/o microtabletas para reducir el uso indebido de por lo menos un principio activo contenido en el mismo; la finalidad de la invención es prevenir el uso inapropiado de una forma de dosis oral basado en microgránulos y/o microtabletas que contienen por lo menos un principio activo capaz de causar una dependencia, un agente gelificante, y un activador gelificante; el agente gelificante y el activador sólo se llevan a contacto uno con otro en el caso de uso inapropiado por trituración; dicho par de excipientes juiciosamente seleccionados confiere una viscosidad a la formulación, de tal manera que la formulación no se pueda administrar mediante inyección o no libere el principio activo rápidamente al formar un gel cuando entre en contacto con la membrana mucosa si se administra por vía nasal.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1054465A FR2960775A1 (fr) | 2010-06-07 | 2010-06-07 | Microgranules resistants au detournement |
FR1055921A FR2960776B1 (fr) | 2010-06-07 | 2010-07-20 | Microgranules et microcomprimes resistants au detournement |
PCT/EP2011/059410 WO2011154414A1 (fr) | 2010-06-07 | 2011-06-07 | Microgranules et microcomprimes resistants au detournement |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012014270A MX2012014270A (es) | 2013-02-12 |
MX345291B true MX345291B (es) | 2017-01-23 |
Family
ID=43499904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012014270A MX345291B (es) | 2010-06-07 | 2011-06-07 | Microgranulos y microtabletas resistentes a uso inapropiado. |
Country Status (13)
Country | Link |
---|---|
US (1) | US9993431B2 (es) |
EP (1) | EP2575789B1 (es) |
JP (1) | JP5937068B2 (es) |
KR (1) | KR101862887B1 (es) |
CN (1) | CN102970984B (es) |
AU (1) | AU2011263780B2 (es) |
CA (1) | CA2800426C (es) |
ES (1) | ES2766349T3 (es) |
FR (2) | FR2960775A1 (es) |
IL (1) | IL223191A (es) |
MX (1) | MX345291B (es) |
WO (1) | WO2011154414A1 (es) |
ZA (1) | ZA201208976B (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
BRPI0906467C1 (pt) | 2008-01-25 | 2021-05-25 | Gruenenthal Gmbh | forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada |
NZ594207A (en) | 2009-02-06 | 2013-03-28 | Egalet Ltd | Immediate release composition resistant to abuse by intake of alcohol |
AU2010265213B2 (en) | 2009-06-24 | 2012-08-23 | Egalet Ltd. | Controlled release formulations |
AU2010275754B2 (en) | 2009-07-22 | 2014-05-15 | Grünenthal GmbH | Tamper-resistant dosage form for oxidation-sensitive opioids |
EP2456427B1 (en) | 2009-07-22 | 2015-03-04 | Grünenthal GmbH | Hot-melt extruded controlled release dosage form |
WO2012028319A1 (en) | 2010-09-02 | 2012-03-08 | Grünenthal GmbH | Tamper resistant dosage form comprising inorganic salt |
MX2013002293A (es) | 2010-09-02 | 2013-05-09 | Gruenenthal Gmbh | Forma de dosificacion resistente a alteracion que comprende un polimero anionico. |
LT2736497T (lt) | 2011-07-29 | 2017-11-10 | Grünenthal GmbH | Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu |
BR112014002022A2 (pt) | 2011-07-29 | 2017-02-21 | Gruenenthal Gmbh | comprimido resistente à violação proporcionando liberação de fármaco imediata |
US20130225697A1 (en) | 2012-02-28 | 2013-08-29 | Grunenthal Gmbh | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
AU2013248351B2 (en) | 2012-04-18 | 2018-04-26 | Grunenthal Gmbh | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
MX362838B (es) | 2012-07-12 | 2019-02-19 | SpecGx LLC | Composiciones farmacéuticas de liberación prolongada para disuadir el abuso de opioides que comprenden un plastómero, un elastómero y un plastificante delicuescente. |
MX2015010041A (es) | 2013-02-05 | 2015-10-30 | Purdue Pharma Lp | Formulacion farmaceuticas resistentes a la alteracion. |
US10751287B2 (en) * | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
JP6466417B2 (ja) | 2013-05-29 | 2019-02-06 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 二峰性放出プロファイルを有する改変防止(tamper−resistant)剤形 |
CA2907950A1 (en) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Tamper-resistant dosage form containing one or more particles |
EA032465B1 (ru) | 2013-07-12 | 2019-05-31 | Грюненталь Гмбх | Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления |
WO2015023675A2 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
US9770514B2 (en) | 2013-09-03 | 2017-09-26 | ExxPharma Therapeutics LLC | Tamper-resistant pharmaceutical dosage forms |
AU2014356581C1 (en) | 2013-11-26 | 2020-05-28 | Grunenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
CN106572980A (zh) | 2014-05-12 | 2017-04-19 | 格吕伦塔尔有限公司 | 包含他喷他多的防篡改即释胶囊制剂 |
CN106456550A (zh) | 2014-05-26 | 2017-02-22 | 格吕伦塔尔有限公司 | 避免乙醇剂量倾泻的多颗粒 |
US9707184B2 (en) | 2014-07-17 | 2017-07-18 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
US9132096B1 (en) | 2014-09-12 | 2015-09-15 | Alkermes Pharma Ireland Limited | Abuse resistant pharmaceutical compositions |
CA2964628A1 (en) | 2014-10-20 | 2016-04-28 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
AU2016251854A1 (en) | 2015-04-24 | 2017-10-19 | Grunenthal Gmbh | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
CA3074694A1 (en) * | 2017-10-02 | 2019-04-11 | Purdue Pharma L.P. | Pharmaceutical compositions comprising delayed release gelling agent compositions |
EP3473246A1 (en) | 2017-10-19 | 2019-04-24 | Capsugel Belgium NV | Immediate release abuse deterrent formulations |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2530563C2 (de) | 1975-07-09 | 1986-07-24 | Bayer Ag, 5090 Leverkusen | Analgetische Arzneimittel mit vermindertem Mißbrauchspotential |
US5811126A (en) * | 1995-10-02 | 1998-09-22 | Euro-Celtique, S.A. | Controlled release matrix for pharmaceuticals |
FR2796840B1 (fr) | 1999-07-26 | 2003-06-20 | Ethypharm Lab Prod Ethiques | Comprimes faiblement doses et procede de preparation |
US7494669B2 (en) * | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
US7842307B2 (en) * | 2001-08-06 | 2010-11-30 | Purdue Pharma L.P. | Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent |
EP1429730A4 (en) * | 2001-09-26 | 2010-06-16 | Penwest Pharmaceuticals Compan | OPIOID FORMULATIONS WITH REDUCED ABUSE POTENTIAL |
ATE371442T1 (de) * | 2001-10-12 | 2007-09-15 | Elan Pharma Int Ltd | Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung |
DE10250084A1 (de) * | 2002-10-25 | 2004-05-06 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
FR2878161B1 (fr) * | 2004-11-23 | 2008-10-31 | Flamel Technologies Sa | Forme medicamenteuse orale, solide et concue pour eviter le mesusage |
FR2881652B1 (fr) * | 2005-02-08 | 2007-05-25 | Flamel Technologies Sa | Forme pharmaceutique orale microparticulaire anti-mesuage |
US8652529B2 (en) * | 2005-11-10 | 2014-02-18 | Flamel Technologies | Anti-misuse microparticulate oral pharmaceutical form |
FR2892937B1 (fr) * | 2005-11-10 | 2013-04-05 | Flamel Tech Sa | Forme pharmaceutique orale microparticulaire anti-mesusage |
WO2008150526A1 (en) | 2007-06-04 | 2008-12-11 | Shear/Kershman Laboratories, Inc. | Tamper resistant lipid-based oral dosage form for opioid agonists |
-
2010
- 2010-06-07 FR FR1054465A patent/FR2960775A1/fr active Pending
- 2010-07-20 FR FR1055921A patent/FR2960776B1/fr active Active
-
2011
- 2011-06-07 CA CA2800426A patent/CA2800426C/fr active Active
- 2011-06-07 KR KR1020137000221A patent/KR101862887B1/ko active IP Right Grant
- 2011-06-07 US US13/702,787 patent/US9993431B2/en active Active
- 2011-06-07 MX MX2012014270A patent/MX345291B/es active IP Right Grant
- 2011-06-07 EP EP11725693.3A patent/EP2575789B1/fr active Active
- 2011-06-07 ES ES11725693T patent/ES2766349T3/es active Active
- 2011-06-07 AU AU2011263780A patent/AU2011263780B2/en active Active
- 2011-06-07 WO PCT/EP2011/059410 patent/WO2011154414A1/fr active Application Filing
- 2011-06-07 CN CN201180027531.4A patent/CN102970984B/zh active Active
- 2011-06-07 JP JP2013513668A patent/JP5937068B2/ja active Active
-
2012
- 2012-11-22 IL IL223191A patent/IL223191A/en active IP Right Grant
- 2012-11-28 ZA ZA2012/08976A patent/ZA201208976B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2800426A1 (fr) | 2011-12-15 |
FR2960775A1 (fr) | 2011-12-09 |
JP2013528194A (ja) | 2013-07-08 |
CA2800426C (fr) | 2020-03-24 |
ZA201208976B (en) | 2013-07-31 |
FR2960776B1 (fr) | 2013-03-29 |
EP2575789B1 (fr) | 2019-10-23 |
US9993431B2 (en) | 2018-06-12 |
IL223191A0 (en) | 2013-02-03 |
FR2960776A1 (fr) | 2011-12-09 |
CN102970984A (zh) | 2013-03-13 |
ES2766349T3 (es) | 2020-06-12 |
IL223191A (en) | 2017-10-31 |
CN102970984B (zh) | 2015-10-14 |
EP2575789A1 (fr) | 2013-04-10 |
AU2011263780B2 (en) | 2015-04-09 |
KR101862887B1 (ko) | 2018-05-30 |
JP5937068B2 (ja) | 2016-06-22 |
US20130129825A1 (en) | 2013-05-23 |
MX2012014270A (es) | 2013-02-12 |
KR20130086200A (ko) | 2013-07-31 |
AU2011263780A1 (en) | 2013-01-10 |
WO2011154414A1 (fr) | 2011-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX345291B (es) | Microgranulos y microtabletas resistentes a uso inapropiado. | |
DE602007010254D1 (de) | Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack | |
WO2012034079A3 (en) | Macrolide dosage forms | |
MX2009000745A (es) | Dispositivos de suministro transmucosa con admision mejorada. | |
WO2012068549A3 (en) | Therapeutic agent formulations for implanted devices | |
MX2015012742A (es) | Capsula resistente al abuso. | |
GB2491328A (en) | Immediate/delayed drug delivery | |
MX2009003771A (es) | Formulaciones robustas de liberacion sostenida. | |
WO2007103293A3 (en) | Ethanol-resistant sustained release formulations | |
WO2009029958A3 (en) | Implantable delivery device | |
EA201290833A1 (ru) | Применение амисульприда в качестве противорвотного средства | |
MX2015008286A (es) | Composiciones multipolimericas para liberación transdermica de farmaco. | |
NZ619857A (en) | A fast dissolving pharmaceutical composition | |
PH12015501982A1 (en) | Pharmaceutical compositions comprising everolimus | |
MX2014008283A (es) | Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta. | |
CO6640264A2 (es) | Combinación de gránulos cargados activos con activos adicionales | |
CO6771406A2 (es) | Una composición combinada | |
MX2017000041A (es) | Formulaciones de liberacion inmediata disuasivas de abuso que comprenden polisacaridos no celulosicos. | |
IN2014DN08598A (es) | ||
TR201010683A1 (tr) | Vildagliptin formülasyonları. | |
CR20170142A (es) | Composiciones farmacéuticas resistentes al abuso | |
MX366707B (es) | Formulaciones y métodos para elaborar formulaciones para utilizarse en evacuación colónica. | |
WO2008028047A3 (en) | Bioadhesive film drug delivery system | |
MX2017004649A (es) | Formulaciones nanoestructuradas para el suministro de silibinina y otros ingredientes activos para tratar enfermedades oculares. | |
WO2012147101A3 (en) | Pharmaceutical compositions of raltegravir, methods of preparation and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |